
a clinical stage orthobiologics company dedicated to the development
of novel therapeutic soft tissue repair technologies to dramatically
improve the success rate of orthopedic and sports medicine surgeries

HOW BIG IS THE SOFT TISSUE REPAIR MARKET?
US$5bn MARKET OPPORTUNITY
Rotator Cuff TEAR
- Leads to shoulder dysfunction and pain
- 4M patients US alone
- 600K annual surgeries US alone
- $600M+ market opportunity
Meniscus Tear Repair
- Painful, compromises knee function
- 1.2M surgeries annually US alone
- $1B+ market opportunity
Cartilage Lesions Repair
- Lesions cause friction and pain
- 1.2M detected lesions annually US alone
- 120K surgeries (lack of options)
- $1B+ market opportunity
STANDARD OF CARE SURGERY HAS HIGH FAILURE RATE
HENCE THE STRONG NEED FOR MORE EFFECTIVE TREATMENTS
ORTHO-R® TECHNOLOGY – NEW PARADIGM
ORTHO-R EASY TO USE AND ADDS 8-10 MINUTES TO STANDARD OF CARE SURGERY
BENEFITS
- Increases PRP residence time for faster & better tissue repair (from less than 24 hours for PRP alone to up to 6 weeks for Ortho-R product)
- Keeps voluminous implant completely covering the surgically repaired site
- Easy to use by orthopedic surgeons
- Better mechanical and biological new tissue properties and faster recovery
- Better tissue formation and integration between tendon and bone
- Safe and gradual and sustain release of growth factors and cytokines from platelets
PRODUCT DEVELOPMENT PORTFOLIO
KEY VALUE MILESTONES
HANUMAN PRP SYSTEM GLOBAL LICENSING DEAL
- Exclusive Global License to use, manufacture, sublicense and sell Product in combination with ORTHO-R
- Fields: Tendons, Ligaments, Meniscus, Cartilage and Wound Healing (non-exclusive)
- Royalty to Hanuman on net sales (on Product)
- New product addition to ORTHO RTI portfolio
- Generates significant revenues to ORTHO RTI in surplus of ORTHO R product
- Perfect complementarity / integration to ORTHO-R
WORLD CLASS PARTNERSHIPS AND COLLABORATORS